Early Stage Finding of an Immune-Enhanced Genetic Subtype of Nonsmall Cell Lung Cancer Related with T-Cell Depletion.

Ying YangQibin ShenHaijun DongTiancheng LiuShunli Dong Dong Li

Published in: Evidence-based complementary and alternative medicine : eCAM (2022)

According to our findings, early-stage NSCLC patients may benefit from receiving treatment with immune checkpoint blockade therapy.

Keyphrases